Biomedical subjects
Publications and source records attributed to L Benassi.
In this study the levels of Estriol and their precursors C(16) substituted in cord plasma are examined. The values found during normal pregnancies are compared with those of pregnancies complicated by different pathology. These compounds can be considered as a good index of feto-placental wellbeing.
Since it is feasible to detect reverse T3 (rT3) in amniotic fluid, we investigated the possibility as to whether measurements of amniotic rT3 could be useful in diagnosing fetal hypothyroidism during pregnancy. In 55 amniotic fluid samples, obtained at different stages of pregnancy, we have documented increasing concentrations of this hormone. The results obtained are conflicting with previous reports. The reason for this discrepancy is not clear, however methodological differences in rT3 determination should be taken in account. The large scatter of rT3 values in amniotic fluid suggests that the diagnosis of neonatal hypothyroidism based on measurement of rT3 may require caution.
Sodium lauryl sulphate (SLS) is an anionic tenside widely utilized in commercial topical preparations that may cause skin irritation. It has been shown that the barrier damage caused by SLS in vivo is lower when SLS is used in combination with other tensides which are able to reduce the critical micelle concentration (CMC). The aim of our study was to evaluate if the cytotoxic effect of SLS is reduced by the association with different tensides also at concentrations well below the CMC. Normal human keratinocytes from plastic surgery were grown in serum-free medium. At subconfluency, the cells were treated with SLS at a dose of 0.0025% in combination with cocamidopropyl betaine, Tween 20 and Tween 80 at the minimum toxic dose. Following tenside treatment, the culture medium was changed, and after 24 h the cells were collected for (3)H-thymidine incorporation, the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) assay and neutral red (NR) uptake. The cytotoxic effect on normal human keratinocytes, as evaluated by (3)H-thymidine incorporation, MTT assay and NR uptake, was significantly decreased by the combination with all the tested tensides. The correlation between cytotoxicity and physical properties was also studied by a conductimetric assay to investigate the mechanism involved in this toxicity reduction.
Recent knowledge on the pathogenetic mechanisms which are thought to be responsible for primary dysmenorrhea in most young females allow us to abandon old therapeutical approaches for several medical solutions with high effectiveness rates. But a number of patients remain for whom these treatments are not suitable or not effective. Mainly for these patients, today we can offer a valid alternative, a new kind of electroanalgesy, TENS, now easier to use owing to the miniaturization of the machine. In fact, in two groups of patients resistant or insensitive to modern medical therapies, we obtained good analgesia during the menstrual period, without important side effects and with high compliance by the patients.
Different therapeutic regimens have been proposed by Authors in the treatment of involutional (and particularly postmenopausal) osteoporosis. Following the up to date concepts on bone remodelling, an ADFR (Activate, Depress, Free, Repeat) trial was performed in 20 females affected by involutional osteoporosis. They were treated with Calcitriol 2 mcg/d for 7 days, followed by a 21 days period of 100 U/d Salmon Calcitonin + 1 g/d Calcitonin, followed by a 2-month period of Calcium alone. The cycles were repeated for 1 year and the results of densitometric examinations (radial mineral content evaluated by single photon absorptiometer, and vertebral mineral content evaluated by dual photon absorptiometer) and of biochemical markers (Ca++, P, osteocalcin, alkaline phosphatase, hydroxyproline) controlled every 3 months, were compared with those obtained in a group of patients treated only with Salmon Calcitonin and in a group treated with Calcium for 1 year. After two therapeutical cycles radial bone mineral density significantly increased; vertebral bone density also increased but not significantly. The effects were more evident in comparison to calcitonin alone treatment. A significant reduction in serum osteocalcin was documented. At the end of the therapy no further improvement was registered. This suggests that some variations and adaptation of therapeutic strategy are needed to achieve a more important and substantial improvement of bone conditions.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.